Language

English

Publication Date

12-23-2025

Journal

Genome Biology

DOI

10.1186/s13059-025-03923-w

PMID

41437377

PMCID

PMC12723928

PubMedCentral® Posted Date

12-23-2025

PubMedCentral® Full Text Version

Post-print

Abstract

Determining tumor-specificity of MHC-bound peptides is crucial for cancer immunotherapy development, yet current methods struggle with class II peptides and non-reference sequences. We introduce PepQueryMHC, an ultra-fast tool that integrates MHC-bound peptide sequences with translated RNA-seq reads for efficient tumor antigen prioritization. We demonstrate its versatility in prioritizing class I and II tumor antigens, mapping the cellular origins of presented peptides, and resolving uncertainties surrounding the prevalence of proteasome-spliced peptides.

Keywords

Antigens, Neoplasm, Humans, Peptides, Histocompatibility Antigens Class I, Histocompatibility Antigens Class II, Software, Neoplasms, Immunopeptidome, Tumor antigens, Immunoinformatics, Proteogenomics, Major histocompatibility complex

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.